← All companies

BHVN

Biohaven Ltd.

BHVN NYSE Pharmaceutical Preparations EDGAR ↗

$16.12

-0.83 -4.90%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

$2.43B

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

-$587M

EPS (TTM) ⓘ

$-4.54

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

-$610M

Cash ⓘ

$238M

Total assets ⓘ

$371M

Gross margin ⓘ

—

52-week range ⓘ

$7.48 – $18.57

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Regulation FD disclosure Aug 26, 2026

8-K Results of operations (earnings release) Aug 10, 2026

10-Q Quarter ended 2026-06-30 Aug 10, 2026

8-K Director or officer change Aug 7, 2026

8-K Director or officer change Jul 9, 2026

8-K Regulation FD disclosure May 27, 2026

8-K Other events May 5, 2026

10-Q Quarter ended 2026-03-31 May 4, 2026

8-K Results of operations (earnings release) May 4, 2026

8-K Shareholder vote results May 4, 2026

8-K Results of operations (earnings release) Mar 2, 2026

10-K Fiscal year ended 2025-12-31 Mar 2, 2026

8-K Regulation FD disclosure Jan 12, 2026

8-K Other events Jan 7, 2026

8-K Other events Nov 13, 2025

10-Q Quarter ended 2025-09-30 Nov 10, 2025

8-K Results of operations (earnings release) Nov 10, 2025

8-K Regulation FD disclosure Aug 22, 2025

8-K Other events Aug 15, 2025

10-Q Quarter ended 2025-06-30 Aug 11, 2025

8-K Results of operations (earnings release) Aug 11, 2025

8-K Regulation FD disclosure Jun 4, 2025

8-K Regulation FD disclosure May 15, 2025

10-Q Quarter ended 2025-03-31 May 12, 2025

8-K Results of operations (earnings release) May 12, 2025

8-K Shareholder vote results May 7, 2025

8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Apr 28, 2025

8-K Results of operations (earnings release) Mar 3, 2025

10-K Fiscal year ended 2024-12-31 Mar 3, 2025

8-K Regulation FD disclosure Jan 13, 2025

8-K Results of operations (earnings release) Nov 12, 2024

10-Q Quarter ended 2024-09-30 Nov 12, 2024

8-K Other events Oct 2, 2024

8-K Regulation FD disclosure; Other events Sep 23, 2024

8-K Other events Aug 16, 2024

8-K Other events Aug 16, 2024

10-Q Quarter ended 2024-06-30 Aug 9, 2024

8-K Results of operations (earnings release) Aug 8, 2024

8-K Other events May 17, 2024

8-K Results of operations (earnings release) May 9, 2024